Target intelligence / Profile preview

Hematopoietic stem and progenitor cell (HSPC) proliferation (HSPC)

Target
HSPC
Molecular classification
Stem cell, Progenitor cell, Other (not a single molecule/receptor)
01

Overview

Hematopoietic stem and progenitor cells reside primarily in the bone marrow and are responsible for the lifelong production and regeneration of all blood cell types through tightly regulated processes of proliferation and differentiation. Their proliferation is critical for responding to physiological demands, recovery after cytotoxic injury, and clinical applications such as transplantation. Regulatory networks controlling HSPC proliferation involve numerous surface receptors (e.g., c-Kit), transcription factors, and extracellular signals; manipulation of this process forms the basis for therapies in hematologic disease and immune reconstitution. The query as stated is not a canonical molecule, receptor, or gene, but a biological process and cell population. Scientific discussion of "hematopoietic stem/progenitor cell proliferation" typically references cellular behaviors or is qualified by the molecular drivers or surface markers of these cells (e.g., "c-Kit receptor," "CD34+ cell proliferation") rather than as a target itself.

Other names
hematopoietic stem cell (HSC)hematopoietic progenitor cell (HPC)HSC/HPC
02

Mechanism of action

Stimulation of HSPC division and mobilization to peripheral blood; Inhibition of differentiation (in some leukemia drugs); Activation or inhibition of surface receptors (e.g., c-Kit, CXCR4)

03

Biological functions

Cell proliferationCell differentiationSelf-renewalBlood cell formation (hematopoiesis)Immune system regeneration
04

Disease associations

Cancer (especially leukemia, lymphoma, myeloma)InflammationImmune deficienciesBone marrow failure syndromesOther blood disorders
05

Safety considerations

Risk of uncontrolled proliferation (leukemia)Myelosuppression (chemotherapy, radiation)Risk of depletion or exhaustion of stem cell poolGraft-vs-host disease (transplant settings)Cytokine storm/overactivation if excessive proliferation induced
06

Interacting drugs

Granulocyte colony-stimulating factor (G-CSF)

3 more in the full profile.

07

Biomarkers

CD34CD45CD43c-KitSca-1CD150/CD48 (mouse studies)

Beyond the preview

Go deeper on Hematopoietic stem and progenitor cell (HSPC) proliferation (HSPC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematopoietic stem and progenitor cell (HSPC) proliferation (HSPC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call